Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168628 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Demitria M Vasilatis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USA. Hauptthemen laut MEDLINE: Receptors, Androgen, Signal Transduction, Prostatic Neoplasms, Epithelial-Mesenchymal Transition. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIH.
Themen: Gewalt gegen Pflegekräfte
Abstract (Originalsprache)
In prostate cancer (PCa), androgens upregulate tumorigenesis, whereas in benign tissue, the revival of androgen receptor (AR) signaling suppresses aggressive behaviors, suggesting therapeutic potential. Dogs, natural PCa models, often lack AR in PCa. We restored AR in dog PCa to investigate resultant characteristics. Three AR-null canine PCa lines (1508, Leo, 1258) were transfected with canine wild-type AR and treated with dihydrotestosterone (DHT). In 1508, AR restoration decreased clonogenicity (p = 0.03), viability (p = 0.004), migration (p = 0.03), invasion (p = 0.01), and increased expression of the tumor suppressor NKX3.1, an AR transcriptional target (p = 0.001). In Leo, AR decreased clonogenicity (p = 0.04) and the expression of another AR transcriptional target FOLH1 (p < 0.001) and increased the expression of NKX3.1 (p = 0.01). In 1258, AR increased migration (p = 0.006) and invasion (p = 0.03). Epithelial–mesenchymal transition (EMT) marker (Vimentin, N-cadherin, SNAIL1) expression increased with AR restoration in Leo and 1258 but not 1508; siRNA vimentin knockdown abrogated AR-induced 1258 migration only. Overall, 1508 showed AR-mediated tumor suppression; AR affected proliferation in Leo but not migration or invasion; and EMT and AR regulated migration and invasion in 1258 but not proliferation. This study highlights the heterogeneous nature of PCa in dogs and cell line-specific effects of AR abrogation on aggressive behaviors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
- Veterans Affairs (VA)-Northern California Healthcare System, Mather, CA 95655, USA.
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
- Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
- Department of Medicine, Medical Clinic III, Hematology Oncology and Palliative Medicine, University Medical Center Rostock, 18057 Rostock, Germany.
ORCID-Profile: Demitria M Vasilatis, Neelu Batra, Christopher A Lucchesi, Eva-Maria Packeiser, Hugo Murua Escobar, Paramita M Ghosh
Förderung
- NIH HHS
- NIH
Zitieren
APA
Vasilatis, D. M., Batra, N., Lucchesi, C. A., Abria, C. J., Packeiser, E. M., Murua Escobar, H., & Ghosh, P. M. (2024). Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168628
Vancouver
Vasilatis DM, Batra N, Lucchesi CA, Abria CJ, Packeiser EM, Murua Escobar H, et al. Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168628
BibTeX
@article{Vasilatis2024,
author = {Vasilatis, Demitria M and Batra, Neelu and Lucchesi, Christopher A and Abria, Christine J and Packeiser, Eva-Maria and Murua Escobar, Hugo and Ghosh, Paramita M},
title = {Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168628}
}
EUVIMED